On June 16th, the "8th Annual Conference of The Shaanxi Association of Traditional Chinese Medicine" sponsored by the Shaanxi Association of Traditional Chinese Medicine, the World Federation of Chinese Medicine Societies Network Disease Professional Committee, the Shaanxi Provincial Association of Traditional Chinese Medicine Network Disease Professional Committee, and the Shaanxi Provincial Hospital of Traditional Chinese Medicine was held in Xi'an, and nearly 400 medical elites from many places across the country attended the meeting site. The meeting was presided over by Xu Jianqin, deputy secretary of the party committee and president of the Shaanxi Provincial Hospital of Traditional Chinese Medicine, Zhou Yaqin, deputy director of the Medical Education Department of the Shaanxi Provincial Administration of Traditional Chinese Medicine, Professor Zhou Yongxue, president of the Shaanxi Association of Traditional Chinese Medicine, Professor Zhang Dexing, vice president and secretary general of the Shaanxi Association of Traditional Chinese Medicine, Professor Wang Ruihui, vice president of Shaanxi University of Traditional Chinese Medicine, Professor Song Guangyao of Hebei Provincial People's Hospital, Professor Zhao Xiaoping, president of the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Professor Yao Juntao, vice president of Shaanxi Provincial Cancer Hospital, and Professor Bai Ling, First Affiliated Hospital of Xi'an Jiaotong University School of Medicine. Professor Zhao Mingjun of the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Professor Song Yunzhang of Shaanxi Provincial People's Hospital, Professor Wang Yangwei of Shaanxi Provincial People's Hospital, Professor Qu Qiumin of the First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Professor Shou Xiling of Shaanxi Provincial People's Hospital, Professor Tuowen, Secretary of the Party Committee of Baoji City Hospital of Traditional Chinese Medicine, and other well-known experts attended the meeting and fully discussed the latest achievements of Tongluo Chinese Medicine in the prevention and treatment of cardiovascular and cerebrovascular diseases, diabetes and other chronic diseases.
Xu Jianqin, deputy secretary of the party committee and president of the Shaanxi Provincial Hospital of Traditional Chinese Medicine, presided over the meeting
In recent years, chronic diseases such as stroke, coronary heart disease, diabetes, and malignant tumors have become more and more serious in the lives and health of Chinese residents, and have become the main cause of death of urban and rural residents. According to statistics, the number of deaths due to chronic diseases in China is as high as 7.376 million per year, which has become a serious threat to the physical and mental health of Chinese residents, and the economic burden caused by chronic diseases has also caused a huge burden on individuals, families and society. From the perspective of Chinese medicine theory, these diseases with long course, repeated onset of pain, and difficult to heal can be classified as network disease. Under the guidance of network disease theory, a series of innovative drugs such as macaroni capsules, ginsengsong yangxin capsules, amaranth capsules, Lianhua Qingyi capsules and other innovative drugs have been developed, which has improved the level of clinical diagnosis and treatment, entered authoritative guidelines/consensuses and teaching materials such as the Chinese Medical Association, and achieved the "Chinese plan" in the era of chronic diseases.
Zhou Yaqin, deputy director of the Medical Education Department of the Shaanxi Provincial Administration of Traditional Chinese Medicine, made an opening speech Zhou Yaqin said in his opening speech that the research team represented by Academician Wu Yiling on the theory of network disease and its application combined the traditional theoretical innovation of traditional Chinese medicine with modern science and technology, produced major original achievements, made a demonstration effect for the inheritance and innovation of traditional Chinese medicine, and played a huge role in promoting the development of traditional Chinese medicine. I hope that all experts and scholars will continue to deepen academic cooperation, and make efforts to deepen the reform of the medical and health system, accelerate the construction of a healthy China, inherit and carry forward the culture of traditional Chinese medicine, and solidly promote the sustained and healthy development of the cause of traditional Chinese medicine!
Professor Zhou Yongxue, President of Shaanxi Association of Traditional Chinese Medicine, delivered an opening speech
Professor Zhou Yongxue said in his speech at the opening ceremony that the Shaanxi Association of Traditional Chinese Medicine Network Disease Professional Committee was established in 2011 to carry out a number of academic lectures, grass-roots physician training, free clinic activities, and promote the theory of Traditional Chinese medicine network disease to take root in Shaanxi. In the future, we will carry out academic exchanges around the theoretical research of network disease and the guidance of clinical application of network drugs, fully study the theoretical development of traditional Chinese medicine network disease, discuss the treatment of traditional Chinese medicine and western medicine, improve clinical efficacy, and jointly promote the rapid development of traditional Chinese medicine.
Professor Zhang Dexing, Vice President and Secretary General of Shaanxi Association of Traditional Chinese Medicine, delivered a speech at the meeting
Professor Zhang Dexing reported on the re-election of the Shaanxi Association of Traditional Chinese Medicine Professional Committee, saying that the special committee currently has 166 members, the scale is growing, indicating that in recent years, clinicians have more and more recognition of the theory of network disease and the advantages of the prevention and treatment of chronic diseases in traditional Chinese medicine; at the same time, many members of Western medicine and integrated traditional Chinese and Western medicine have been absorbed, forming a multi-clinical framework of traditional Chinese medicine, Western medicine, and integrated traditional Chinese and Western medicine, and the development of members has deepened from provincial and municipal hospitals to county-level hospitals, and more grass-roots doctors have been recruited.
Professor Zhao Mingjun of the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine made an academic report
In the academic report session, Professor Zhao Mingjun shared the special lecture on "The Construction of The Choroid Theory and Its Guidance on the Prevention and Treatment of Microvascular Lesions", pointing out that the "Choroid Theory" is a systematic original theory that guides the treatment of vascular lesions, and truly realizes the treatment of microvascular lesions in traditional Chinese medicine by opening up a chain of pathway drugs to inhibit cardiovascular events. At the same time, with the clinical evidence-based evidence evaluation of efficacy as a means, constantly revealing the mechanism of action of Tongluo Chinese medicine, making continuous breakthroughs in the field of cardiovascular disease treatment, a number of research results have produced major international academic impact, and papers targeted at Tongluo Chinese medicine have been published in top journals in the cardiovascular field (Journal of the American College of Cardiology, Nature Review: Cardiology, etc.), such as the 1212 cases of evidence-based research led by Academician Zhang Yun of the Chinese Academy of Engineering recently published in the sub-journal of the international authoritative journal "Nature", It was found that the cardiac capsule can safely and effectively reduce the thickness of the carotid artery median membrane, plaque area and vascular remodeling index, which confirms the role of the macaroni capsule in targeted intervention plaque, thereby reducing the risk of cardiovascular events. A series of research evidence has made Tongluo Chinese medicine unanimously recognized by experts and scholars at home and abroad, highlighting the good prospects of Chinese medicine in the treatment of cardiovascular and cerebrovascular diseases.
Professor Song Guangyao of Hebei Provincial People's Hospital made an academic report
In addition, Professor Song Guangyao interpreted the 2017 edition of the 2017 version of the guidelines for the prevention and treatment of type 2 diabetes at the meeting, emphasizing that the drug treatment of hyperglycemia should be more active, flexible and individualized, metformin has a cornerstone position in the whole treatment process, and on the basis of diet control, exercise therapy and metformin stable dose treatment, the combined use of Jinlida granules with high-level evidence-based medical evidence can make the glycosylated hemoglobin in patients with type 2 diabetes be better controlled, and have potential therapeutic advantages in reducing waist circumference and alleviating complications.
Professor Bai Ling of the First Affiliated Hospital of Xi'an Jiaotong University School of Medicine made an academic report
Professor Bai Ling introduced the evidence of evidence-based research obtained by Alfalfa Heart Strengthening Capsules in the report, including significantly reducing the serum amino terminal brain natriure peptide precursor (NT-proBNP) level in patients with chronic heart failure, increasing the patient's walking distance by 6 minutes, improving the patient's symptoms and quality of life and improving the patient's left ventricular ejection fraction (LVEF), reducing the incidence of compound endpoint events, etc., and calling for high-risk groups with heart failure with hypertension, coronary artery disease and rheumatic heart disease to be screened in a timely manner. Controlling risk factors and interfering with lifestyle can help prevent the risk of left ventricular dysfunction or new-onset heart failure.
Professor Qu Qiumin of the First Affiliated Hospital of Xi'an Jiaotong University School of Medicine made an academic report
Professor Qu Qiumin said that many stroke patients will have cognitive impairment within 6 months after the onset of the disease, and their pathogenesis and disease process are quite complex, which should be identified early and actively intervened, which is a common clinical problem and should be highly valued.
Professor Shou Xiling of Shaanxi Provincial People's Hospital made an academic report
Professor Shou Xiling introduced a common clinical arrhythmias such as atrial fibrillation in his report, pointing out that advanced age, heart failure, hypertension, diabetes, left atrial enlargement, left ventricular dysfunction, etc. may become risk factors for the recurrence of atrial fibrillation, requiring patients to take anti-arrhythmia drugs for a long time, so the safety of drugs is crucial. At present, the commonly used Western medicines in clinical practice are amiodarone, dofetilide, propafenone, etc., and as the only traditional Chinese medicine with relevant evidence-based medical evidence, the efficacy of treating paroxysmal atrial fibrillation is comparable to that of Western medicine arrhythmia, and the safety is better than that of arrhythmia.
Professor Song Yunzhang of Shaanxi Provincial People's Hospital was interviewed by the media
Professor Wang Yangwei of Shaanxi Provincial People's Hospital was interviewed by the media
During the meeting, Professor Zhao Mingjun, Director of the Department of Cardiology of the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Professor Song Yunzhang, Director of the Department of Neurology of Shaanxi Provincial People's Hospital, Professor Qu Qiumin, Director of the Department of Neurology of the First Affiliated Hospital of Xi'an Jiaotong University, and Professor Wang Yangwei, Director of the Department of Endocrinology of Shaanxi Provincial People's Hospital, were interviewed by a number of media and spoke highly of the results achieved by Tongluo Chinese Medicine in a series of evidence-based research.
The research of network disease has experienced 40 years of spring and autumn, during which major achievements have emerged, the international influence has gradually increased, the international cooperation and exchanges have been strengthened, the society of network disease has flourished, and a large number of outstanding experts and teams have emerged. At this academic event, Professor Zhou Yongxue, Professor Wang Ruihui and Professor Zhang Dexing commended these experts and teams, and awarded them the honorary titles of "Outstanding Experts in the Promotion of Network Studies for 40 Years", "Experts with Outstanding Contributions to Network Studies in the Past 40 Years" and "Meritorious Experts in the Development of Network Studies for 40 Years".
Professor Zhang Dexing, Vice President and Secretary General of Shaanxi Association of Traditional Chinese Medicine (fifth from the right), awarded the "Outstanding Expert of 40 Years of Network Science Promotion"
Professor Wang Ruihui, Vice President of Shaanxi University of Traditional Chinese Medicine (first from the left), awarded the "Expert with Outstanding Contribution to 40 Years of Network Research"
Professor Zhou Yongxue, President of Shaanxi Association of Traditional Chinese Medicine (middle), awarded "Meritorious Expert of 40 Years of NetworkIng"